Endocrine factors modulating immune responses in pregnancy

Frontiers in Immunology

Volumn 5, Issue MAY, 2014, Pages

  Schumacher, Anne ^a   Costa, Serban Dan ^a   Zenclussen, Ana Claudia ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Alpha fetoprotein; Estradiol; Human chorionic gonadotropin; Immune regulation; Luteinizing hormone; Pregnancy; Progesterone

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 7; LUTEINIZING HORMONE; MICRORNA 155; PROGESTERONE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

B LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DENDRITIC CELL; EMBRYO TRANSFER; ENDOCRINE SYSTEM; FERTILIZATION IN VITRO; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFERTILITY THERAPY; MACROPHAGE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PREGNANCY; PREGNANCY TERMINATION; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TH1 TH2 BALANCE;

EID: 84905494424     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00196     Document Type: Review

References (184)

1. Chambers SP, Clarke AG. Measurement of thymus weight, lumbar node weight and progesterone levels in syngeneically pregnant, allogeneically pregnant, and pseudopregnant mice. J Reprod Fertil (1979) 55(2):309-15. doi: 10.1530/jrf.0.0550309
2. Stewart DR, Overstreet JW, Nakajima ST, Lasley BL. Enhanced ovarian steroid secretion before implantation in early human pregnancy. J Clin Endocrinol Metab (1993) 76(6):1470-6. doi:10.1210/jcem.76.6.8501152
3. Szekeres-Bartho J, Balasch J. Progestogen therapy for recurrent miscarriage. Hum Reprod Update (2008) 14(1):27-35. doi:10.1093/humupd/dmm035
4. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med (2001) 345(19):1400-8. doi:10.1056/NEJMra000763
5. Costea DM, Gunn LK, Hargreaves C, Howell RJ, Chard T. Delayed luteo-placental shift of progesterone production in IVF pregnancy. Int J Gynaecol Obstet (2000) 68(2):123-9. doi:10.1016/S0020-7292(99)00177-0
6. Mendelson CR. Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol (2009) 23(7):947-54. doi:10.1210/me.2009-0016
7. Ramathal CY, Bagchi IC, Taylor RN, Bagchi MK. Endometrial decidualization: of mice and men. Semin Reprod Med (2010) 28(1):17-26. doi:10.1055/s-0029-1242989
8. Goldman S, Shalev E. Progesterone receptor profile in the decidua and fetal membrane. Front Biosci (2007) 12:634-48. doi:10.2741/2088
9. Kowalik MK, Rekawiecki R, Kotwica J. The putative roles of nuclear and membrane-bound progesterone receptors in the female reproductive tract. Reprod Biol (2013) 13(4):279-89. doi:10.1016/j.repbio.2013.09.001
10. Szekeres-Bartho J, Wilczynski JR, Basta P, Kalinka J. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci (2008) 13:1981-90. doi:10.2741/2817
11. Alok A, Mukhopadhyay D, Karande AA. Glycodelin A, an immunomodulatory protein in the endometrium, inhibits proliferation and induces apoptosis in monocytic cells. Int J Biochem Cell Biol (2009) 41(5):1138-47. doi:10.1016/j.biocel.2008.10.009
12. Ozawa H. Steroid hormones, their receptors and neuroendocrine system. J Nippon Med Sch (2005) 72(6):316-25. doi:10.1272/jnms.72.316
13. Mihm M, Gangooly S, Muttukrishna S. The normal menstrual cycle in women. Anim Reprod Sci (2011) 124(3-4):229-36. doi:10.1016/j.anireprosci.2010.08.030
14. Pasqualini JR. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol (2005) 97(5):401-15. doi:10.1016/j.jsbmb.2005.08.004
15. Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol (2005) 19(8):1951-9. doi:10.1210/me.2004-0390
16. Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy (2004) 3(1):97-104. doi:10.2174/1568010043483944
17. Mao A, Paharkova-Vatchkova V, Hardy J, Miller MM, Kovats S. Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J Immunol (2005) 175(8):5146-51. doi:10.4049/jimmunol.175.8.5146
18. Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol (2010) 8(1):102. doi:10.1186/1477-7827-8-102
19. Braunstein GD, Rasor J, Danzer H, Adler D, Wade ME. Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol (1976) 126(6):678-81.
20. Handschuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D, et al. Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. Placenta (2007) 28(2-3):175-84. doi:10.1016/j.placenta.2006.01.019
21. Fluhr H, Bischof-Islami D, Krenzer S, Licht P, Bischof P, Zygmunt M. Human chorionic gonadotropin stimulates matrix metalloproteinases-2 and -9 in cytotrophoblastic cells and decreases tissue inhibitor of metalloproteinases-1, -2, and -3 in decidualized endometrial stromal cells. Fertil Steril (2008) 90(4):1390-5. doi:10.1016/j.fertnstert.2007.08.023
22. Környei JL, Lei ZM, Rao CV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol Reprod (1993) 49(6):1149-57. doi:10.1095/biolreprod49.6.1149
23. Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol (2003) 171(5):2305-13. doi:10.4049/jimmunol.171.5.2305
24. Berndt S, Perrier d'Hauterive S, Blacher S, Péqueux C, Lorquet S, Munaut C, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J (2006) 20(14):2630-2. doi:10.1096/fj.06-5885fje
25. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Münstedt K, Rao CV, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab (2002) 87(11):5290-6. doi:10.1210/jc.2002-020642
26. Fujimoto A, Osuga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M, et al. Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet (2002) 19(12):550-4. doi:10.1023/A:1021207014429
27. Lafuste P, Robert B, Mondon F, Danan JL, Rossi B, Duc-Goiran P, et al. Alpha-fetoprotein gene expression in early and full-term human trophoblast. Placenta (2002) 23(8-9):600-12. doi:10.1053/plac.2002.0816
28. Tomasi TB. Structure and function of alpha-fetoprotein. Annu Rev Med (1977) 28:453-65. doi:10.1146/annurev.me.28.020177.002321
29. Laan-Pütsep K, Wigzell H, Cotran P, Gidlund M. Human alpha-fetoprotein (AFP) causes a selective down regulation of monocyte MHC class II molecules without altering other induced or noninduced monocyte markers or functions in monocytoid cell lines. Cell Immunol (1991) 133(2):506-18. doi:10.1016/0008-8749(91)90122-R
30. Chakraborty M, Mandal C. Immuno-suppressive effect of human alphafetoprotein: a cross species study. Immunol Invest (1993) 22(5):329-39. doi:10.3109/08820139309063412
31. Wang W, Alpert E. Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein. Hepatology (1995) 22(3):921-8. doi:10.1002/hep.1840220333
32. Um SH, Mulhall C, Alisa A, Ives AR, Karani J, Williams R, et al. Alpha-fetoprotein impairs APC function and induces their apoptosis. J Immunol (2004) 173(3):1772-8. doi:10.4049/jimmunol.173.3.1772
33. Tonello A, Poli G. Tubal ectopic pregnancy: macrophages under the microscope. Hum Reprod (2007) 22(10):2577-84. doi:10.1093/humrep/dem246
34. Zhang YM, Rao CV, Lei ZM. Macrophages in human reproductive tissues contain luteinizing hormone/chorionic gonadotropin receptors. Am J Reprod Immunol (2003) 49(2):93-100. doi:10.1034/j.1600-0897.2003.00013.x
35. Bukovsky A, Indrapichate K, Fujiwara H, Cekanova M, Ayala ME, Dominguez R, et al. Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease. Reprod Biol Endocrinol (2003) 1:46. doi:10.1186/1477-7827-1-46
36. Hunt JS, Miller L, Platt JS. Hormonal regulation of uterine macrophages. Dev Immunol (1998) 6(1-2):105-10. doi:10.1155/1998/87527
37. Kitzmiller JL, Rocklin RE. Lack of suppression of lymphocyte MIF production by estradiol, progesterone and human chorionic gonadotropin. J Reprod Immunol (1980) 1(5-6):297-306. doi:10.1016/0165-0378(80)90003-0
38. Cervar M, Blaschitz A, Dohr G, Desoye G. Paracrine regulation of distinct trophoblast functions in vitro by placental macrophages. Cell Tissue Res (1999) 295(2):297-305. doi:10.1007/s004410051236
39. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci (2005) 38(1):1-7. doi:10.1016/j.jdermsci.2004.10.011
40. Guimerà M, Morales-Ruiz M, Jiménez W, Balasch J. LH/HCG stimulation of VEGF and adrenomedullin production by follicular fluid macrophages and luteinized granulosa cells. Reprod Biomed Online (2009) 18(6):743-9. doi:10.1016/S1472-6483(10)60021-1
41. Polan ML, Kuo A, Loukides J, Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J Clin Endocrinol Metab (1990) 70(2):480-4. doi:10.1210/jcem-70-2-480
42. Kim HM, Moon YH. Human chorionic gonadotropin induces nitric oxide synthase mRNA in mouse peritoneal macrophages. Biochem Biophys Res Commun (1996) 229(2):548-52. doi:10.1006/bbrc.1996.1841
43. Sun Y, Cai J, Ma F, Lü P, Huang H, Zhou J. miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol Lett (2012) 146(1-2):25-30. doi:10.1016/j.imlet.2012.04.007
44. Menzies FM, Henriquez FL, Alexander J, Roberts CW. Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology (2011) 134(3):281-91. doi:10.1111/j.1365-2567.2011.03488.x
45. Wan H, Versnel MA, Cheung WY, Leenen PJM, Khan NA, Benner R, et al. Chorionic gonadotropin can enhance innate immunity by stimulating macrophage function. J Leukoc Biol (2007) 82(4):926-33. doi:10.1189/jlb.0207092
46. Abu Alshamat E, Al-Okla S, Soukkarieh CH, Kweider M. Human chorionic gonadotrophin (hCG) enhances immunity against L. tropica by stimulating human macrophage functions. Parasite Immunol (2012) 34(10):449-54. doi:10.1111/j.1365-3024.2012.01368.x
47. Sonoda N, Katabuchi H, Tashiro H, Ohba T, Nishimura R, Minegishi T, et al. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages. Placenta (2005) 26(4):298-307. doi:10.1016/j.placenta.2004.07.001
48. Katabuchi H, Ohba T. Human chorionic villous macrophages as a fetal biological shield from maternal chorionic gonadotropin. Dev Growth Differ (2008) 50(5):299-306. doi:10.1111/j.1440-169X.2008.01030.x
49. Yamaguchi M, Ohba T, Tashiro H, Yamada G, Katabuchi H. Human chorionic gonadotropin induces human macrophages to form intracytoplasmic vacuoles mimicking Hofbauer cells in human chorionic villi. Cells Tissues Organs (2013) 197(2):127-35. doi:10.1159/000342806
50. Lu CY, Changelian PS, Unanue ER. Alpha-fetoprotein inhibits macrophage expression of Ia antigens. J Immunol (1984) 132(4):1722-7.
51. Hatta K, Carter AL, Chen Z, Leno-Duran E, Ruiz-Ruiz C, Olivares EG, et al. Expression of the vasoactive proteins AT1, AT2, and ANP by pregnancy-induced mouse uterine natural killer cells. Reprod Sci (2011) 18(4):383-90. doi:10.1177/1933719110385136
52. Wang C, Umesaki N, Nakamura H, Tanaka T, Nakatani K, Sakaguchi I, et al. Expression of vascular endothelial growth factor by granulated metrial gland cells in pregnant murine uteri. Cell Tissue Res (2000) 300(2):285-93. doi:10.1007/s004410000198
53. Tayade C, Hilchie D, He H, Fang Y, Moons L, Carmeliet P, et al. Genetic deletion of placenta growth factor in mice alters uterine NK cells. J Immunol (2007) 178(7):4267-75. doi:10.4049/jimmunol.178.7.4267
54. Ashkar AA, Croy BA. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol (2001) 13(4):235-41. doi:10.1006/smim.2000.0319
55. Borzychowski AM, Chantakru S, Minhas K, Paffaro VA, Yamada AT, He H, et al. Functional analysis of murine uterine natural killer cells genetically devoid of oestrogen receptors. Placenta (2003) 24(4):403-11. doi:10.1053/plac.2002.0924
56. van den Heuvel MJ, Horrocks J, Bashar S, Taylor S, Burke S, Hatta K, et al. Menstrual cycle hormones induce changes in functional interactions between lymphocytes and decidual vascular endothelial cells. J Clin Endocrinol Metab (2005) 90(5):2835-42. doi:10.1210/jc.2004-1742
57. Carlino C, Stabile H, Morrone S, Bulla R, Soriani A, Agostinis C, et al. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood (2008) 111(6):3108-15. doi:10.1182/blood-2007-08-105965
58. Kuang H, Peng H, Xu H, Zhang B, Peng J, Tan Y. Hormonal regulation of uterine natural killer cells in mouse preimplantation uterus. J Mol Histol (2010) 41(1):1-7. doi:10.1007/s10735-010-9256-8
59. Inoue T, Kanzaki H, Imai K, Narukawa S, Katsuragawa H, Watanabe H, et al. Progesterone stimulates the induction of human endometrial CD56+ lymphocytes in an in vitro culture system. J Clin Endocrinol Metab (1996) 81(4):1502-7. doi:10.1210/jcem.81.4.8636358
60. Qu X, Yang M, Zhang W, Liang L, Yang Y, Zhang Y, et al. Osteopontin expression in human decidua is associated with decidual natural killer cells recruitment and regulated by progesterone. In vivo (2008) 22(1):55-61.
61. van den Heuvel MJ, Xie X, Tayade C, Peralta C, Fang Y, Leonard S, et al. A review of trafficking and activation of uterine natural killer cells. Am J Reprod Immunol (2005) 54(6):322-31. doi:10.1111/j.1600-0897.2005.00336.x
62. King A, Gardner L, Loke YW. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum Reprod (1996) 11(5):1079-82. doi:10.1093/oxfordjournals.humrep.a019300
63. Henderson TA, Saunders PTK, Moffett-King A, Groome NP, Critchley HOD. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab (2003) 88(1):440-9. doi:10.1210/jc.2002-021174
64. Oh M-J, Croy B. A map of relationships between uterine natural killer cells and progesterone receptor expressing cells during mouse pregnancy. Placenta (2008) 29(4):317-23. doi:10.1016/j.placenta.2008.01.003
65. Guo W, Li P, Zhao G, Fan H, Hu Y, Hou Y. Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells. Am J Reprod Immunol (2012) 67(6):463-73. doi:10.1111/j.1600-0897.2012.01114.x
66. Kane N, Kelly R, Saunders PTK, Critchley HOD. Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. Endocrinology (2009) 150(6):2882-8. doi:10.1210/en.2008-1309
67. Hansen KA, Opsahl MS, Nieman LK, Baker JR, Klein TA. Natural killer cell activity from pregnant subjects is modulated by RU 486. Am J Obstet Gynecol (1992) 166(1 Pt 1):87-90. doi:10.1016/0002-9378(92)91835-X
68. Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Z, Palkovics T, et al. The role of gamma/delta T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol (1999) 42(1):44-8. doi:10.1111/j.1600-0897.1999.tb00464.x
69. Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol (1999) 42(2):71-5.
70. Laskarin G, Tokmadzic VS, Strbo N, Bogovic T, Szekeres-Bartho J, Randic L, et al. Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol (2002) 48(4):201-9. doi:10.1034/j.1600-0897.2002.01133.x
71. Gabrilovac J, Zadjelovic J, Osmak M, Suchanek E, Zupanovic Z, Boranic M. NK cell activity and estrogen hormone levels during normal human pregnancy. Gynecol Obstet Invest (1988) 25(3):165-72. doi:10.1159/000293766
72. Hao S, Zhao J, Zhou J, Zhao S, Hu Y, Hou Y. Modulation of 17beta-estradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors. Int Immunopharmacol (2007) 7(13):1765-75. doi:10.1016/j.intimp.2007.09.017
73. Kurashige T, Morita H, Ogura H, Kurashige M, Kitamura I, Kamimura O. The effects of hormone and protein increases during pregnancy on natural killer (NK) cell activity. Asia Oceania J Obstet Gynaecol (1986) 12(3):403-7. doi:10.1111/j.1447-0756.1986.tb00211.x
74. Kitaya K, Yasuda J, Nakayama T, Fushiki S, Honjo H. Effect of female sex steroids on human endometrial CD16neg CD56bright natural killer cells. Fertil Steril (2003) 79(Suppl 1):730-4. doi:10.1016/S0015-0282(02)04818-5
75. Papademetriou V, Bartocci A, Stylos WA, Chirigos MA. Augmentation of cytotoxicity by splenic cells of pregnant or human chorionic gonadotropin-treated normal mice. J Immunopharmacol (1980) 2(3):309-24. doi:10.3109/08923978009046464
76. Sulke AN, Jones DB, Wood PJ. Hormonal modulation of human natural killer cell activity in vitro. J Reprod Immunol (1985) 7(2):105-10. doi:10.1016/0165-0378(85)90064-6
77. Alexander H, Zimmermann G, Lehmann M, Pfeiffer R, Schöne E, Leiblein S, et al. HCG secretion by peripheral mononuclear cells during pregnancy. Domest Anim Endocrinol (1998) 15(5):377-87. doi:10.1016/S0739-7240(98)00025-3
78. Alvarez-Errico D, Lessmann E, Rivera J. Adapters in the organization of mast cell signaling. Immunol Rev (2009) 232(1):195-217. doi:10.1111/j.1600-065X.2009.00834.x
79. Shelburne CP, Abraham SN. The mast cell in innate and adaptive immunity. Adv Exp Med Biol (2011) 716:162-85. doi:10.1007/978-1-4419-9533-9_10
80. Woidacki K, Popovic M, Metz M, Schumacher A, Linzke N, Teles A, et al. Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death Dis (2013) 4(1):e462. doi:10.1038/cddis.2012.214
81. Mori A, Zhai YL, Toki T, Nikaido T, Fujii S. Distribution and heterogeneity of mast cells in the human uterus. Hum Reprod (1997) 12(2):368-72. doi:10.1093/humrep/12.2.368
82. Padilla L, Reinicke K, Montesino H, Villena F, Asencio H, Cruz M, et al. Histamine content and mast cells distribution in mouse uterus: the effect of sexual hormones, gestation and labor. Cell Mol Biol (1990) 36(1):93-100.
83. Gibbons AF, Chang MC. Number of mast cells in the rat uterus with special reference to its relation to hormonal treatment and decidual response. Biol Reprod (1972) 6(2):193-203.
84. Wordinger RJ, Orr EL, Pace K, Oakford L, Morrill A. An assessment of mast-cell deficient mice (W/Wv) as a model system to study the role of histamine in implantation and deciduoma formation. J Reprod Fertil (1985) 73(2):451-6. doi:10.1530/jrf.0.0730451
85. Jing H, Wang Z, Chen Y. Effect of oestradiol on mast cell number and histamine level in the mammary glands of rat. Anat Histol Embryol (2012) 41(3):170-6. doi:10.1111/j.1439-0264.2011.01120.x
86. Jensen F, Woudwyk M, Teles A, Woidacki K, Taran F, Costa S, et al. Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation. PLoS One (2010) 5(12):e14409. doi:10.1371/journal.pone.0014409
87. Chancey AL, Gardner JD, Murray DB, Brower GL, Janicki JS. Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen. Am J Physiol Heart Circ Physiol (2005) 289(1):H316-21. doi:10.1152/ajpheart.00765.2004
88. Vasiadi M, Kempuraj D, Boucher W, Kalogeromitros D, Theoharides TC. Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol (2006) 19(4):787-94.
89. Zaitsu M, Narita S-I, Lambert KC, Grady JJ, Estes DM, Curran EM, et al. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol (2007) 44(8):1977-85. doi:10.1016/j.molimm.2006.09.030
90. Narita S-I, Goldblum RM, Watson CS, Brooks EG, Estes DM, Curran EM, et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect (2007) 115(1):48-52. doi:10.1289/ehp.9378
91. Bergman F, Damber MG, Lindén U, Paul KG. Mast cells and eosinophil granulocytes in the oestrogen-stimulated mouse uterus. Acta Endocrinol (1972) 69(1):77-86.
92. Cocchiara R, Albeggiani G, Di Trapani G, Azzolina A, Lampiasi N, Rizzo F, et al. Oestradiol enhances in vitro the histamine release induced by embryonic histamine-releasing factor (EHRF) from uterine mast cells. Hum Reprod (1992) 7(8):1036-41.
93. Hunt JS, Miller L, Roby KF, Huang J, Platt JS, DeBrot BL. Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes. J Reprod Immunol (1997) 35(2):87-99. doi:10.1016/S0165-0378(97)00060-0
94. Theoharides TC, Dimitriadou V, Letourneau R, Rozniecki JJ, Vliagoftis H, Boucher W. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience (1993) 57(3):861-71. doi:10.1016/0306-4522(93)90030-J
95. Erlik Y, Naot Y, Friedman M, Ben-David E, Paldi E. Histamine levels in ovarian hyperstimulation syndrome. Obstet Gynecol (1979) 53(5):580-2.
96. Kämmerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TBH, Dietl J, et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol (2003) 162(3):887-96. doi:10.1016/S0002-9440(10)63884-9
97. Blois SM, Alba Soto CD, Tometten M, Klapp BF, Margni RA, Arck PC. Lineage, maturity, and phenotype of uterine murine dendritic cells throughout gestation indicate a protective role in maintaining pregnancy. Biol Reprod (2004) 70(4):1018-23. doi:10.1095/biolreprod.103.022640
98. Blois S, Tometten M, Kandil J, Hagen E, Klapp BF, Margni RA, et al. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J Immunol (2005) 174(4):1820-9. doi:10.4049/jimmunol.174.4.1820
99. Askelund K, Liddell HS, Zanderigo AM, Fernando NS, Khong TY, Stone PR, et al. CD83(+) dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta (2004) 25(2-3):140-5. doi:10.1016/S0143-4004(03)00182-6
100. Plaks V, Birnberg T, Berkutzki T, Sela S, BenYashar A, Kalchenko V, et al. Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest (2008) 12:3954-65. doi:10.1172/JCI36682
101. Butts CL, Shukair SA, Duncan KM, Bowers E, Horn C, Belyavskaya E, et al. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol (2007) 19(3):287-96. doi:10.1093/intimm/dxl145
102. Kovats S. Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm Behav (2012) 62(3):254-62. doi:10.1016/j.yhbeh.2012.04.011
103. Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K, et al. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol (2013) 190(6):2650-8. doi:10.4049/jimmunol.1202698
104. Xu Y, He H, Li C, Shi Y, Wang Q, Li W, et al. Immunosuppressive effect of progesterone on dendritic cells in mice. J Reprod Immunol (2011) 91(1-2):17-23. doi:10.1016/j.jri.2011.06.101
105. Wan H, Versnel MA, Leijten LME, van Helden-Meeuwsen CG, Fekkes D, Leenen PJM, et al. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J Leukoc Biol (2008) 83(4):894-901. doi:10.1189/jlb.0407258
106. Huck B, Steck T, Habersack M, Dietl J, Kämmerer U. Pregnancy associated hormones modulate the cytokine production but not the phenotype of PBMC-derived human dendritic cells. Eur J Obstet Gynecol Reprod Biol (2005) 122(1):85-94. doi:10.1016/j.ejogrb.2005.02.017
107. Uemura Y, Liu T-Y, Narita Y, Suzuki M, Matsushita S. 17β-Estradiol (E2) plus tumor necrosis factor-α induces a distorted maturation of human monocyte-derived dendritic cells and promotes their capacity to initiate T-helper 2 responses. Hum Immunol (2008) 69(3):149-57. doi:10.1016/j.humimm.2008.01.017
108. Segerer SE, Müller N, van Den Brandt J, Kapp M, Dietl J, Reichardt HM, et al. Impact of female sex hormones on the maturation and function of human dendritic cells. Am J Reprod Immunol (2009) 62(3):165-73. doi:10.1111/j.1600-0897.2009.00726.x
109. Kyurkchiev D, Ivanova-Todorova E, Hayrabedyan S, Altankova I, Kyurkchiev S. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. Am J Reprod Immunol (2007) 58(5):425-33. doi:10.1111/j.1600-0897.2007.00526.x
110. Xiao B-G, Liu X, Link H. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis. Steroids (2004) 69(10):653-9. doi:10.1016/j.steroids.2004.05.019
111. Zhu WH, Lu CZ, Huang YM, Link H, Xiao BG. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult Scler (2007) 13(1):33-40. doi:10.1177/1352458506071171
112. Ueno A, Cho S, Cheng L, Wang J, Hou S, Nakano H, et al. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes (2007) 56(6):1686-93. doi:10.2337/db06-1727
113. Negishi Y, Wakabayashi A, Shimizu M, Ichikawa T, Kumagai Y, Takeshita T, et al. Disruption of maternal immune balance maintained by innate DC subsets results in spontaneous pregnancy loss in mice. Immunobiology (2012) 217(10):951-61. doi:10.1016/j.imbio.2012.01.011
114. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol (2013) 91(9):545-55. doi:10.1038/icb.2013.38
115. Porakishvili N, Mageed R, Jamin C, Pers JO, Kulikova N, Renaudineau Y, et al. Recent progress in the understanding of B-cell functions in autoimmunity. Scand J Immunol (2001) 54(1-2):30-8. doi:10.1046/j.1365-3083.2001.00950.x
116. Youinou P, Jamin C, Pers J-O, Berthou C, Saraux A, Renaudineau Y. B lymphocytes are required for development and treatment of autoimmune diseases. Ann N Y Acad Sci (2005) 1050:19-33. doi:10.1196/annals.1313.003
117. Muzzio D, Zenclussen AC, Jensen F. The role of B cells in pregnancy: the good and the bad. Am J Reprod Immunol (2013) 69(4):408-12. doi:10.1111/aji.12079
118. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood (2008) 112(5):1570-80. doi:10.1182/blood-2008-02-078071
119. Kantor AB, Stall AM, Adams S, Herzenberg LA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci U S A (1992) 89(8):3320-4. doi:10.1073/pnas.89.8.3320
120. Montecino-Rodriguez E, Dorshkind K. New perspectives in B-1 B cell development and function. Trends Immunol (2006) 27(9):428-33. doi:10.1016/j.it.2006.07.005
121. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev (2006) 5(6):403-8. doi:10.1016/j.autrev.2005.10.007
122. Jensen F, Wallukat G, Herse F, Budner O, El-Mousleh T, Costa S-D, et al. CD19+CD5+ cells as indicators of preeclampsia. Hypertension (2012) 59(4):861-8. doi:10.1161/HYPERTENSIONAHA.111.188276
123. Hammarström L, Fuchs T, Smith CI. The immunodepressive effect of human glucoproteins and their possible role in the nonrejection process during pregnancy. Acta Obstet Gynecol Scand (1979) 58(5):417-22. doi:10.3109/00016347909154059
124. Nikolaevich KN, Ivanovich SJ, Victorovich SS. Major reproduction hormones as regulators of cell-to-cell interactions in humoral immune responses. Brain Behav Immun (1991) 5(2):149-61. doi:10.1016/0889-1591(91)90013-Z
125. Margni RA, Paz CB, Cordal ME. Immunochemical behavior of sheep non-precipitating antibodies isolated by immunoadsorption. Immunochemistry (1976) 13(3):209-14. doi:10.1016/0019-2791(76)90217-2
126. Malan Borel I, Gentile T, Angelucci J, Pividori J, Guala MC, Binaghi RA, et al. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol (1991) 20(2):129-40. doi:10.1016/0165-0378(91)90029-P
127. Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R. Asymmetric antibodies and pregnancy. Am J Reprod Immunol (2001) 45(5):289-94. doi:10.1111/j.8755-8920.2001.450504.x
128. Canellada A, Blois S, Gentile T, Margni Idehu RA. In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am J Reprod Immunol (2002) 48(5):334-43. doi:10.1034/j.1600-0897.2002.01141.x
129. Kelemen K, Bognar I, Paal M, Szekeres-Bartho J. A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol (1996) 167(1):129-34. doi:10.1006/cimm.1996.0016
130. Kincade PW, Medina KL, Smithson G. Sex hormones as negative regulators of lymphopoiesis. Immunol Rev (1994) 137:119-34. doi:10.1111/j.1600-065X.1994.tb00661.x
131. Caldwell JL, Stites DP, Fudenberg HH. Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation. J Immunol (1975) 115(5):1249-53.
132. Beck D, Ginsburg H, Naot Y. The modulating effect of human chorionic gonadotropin on lymphocyte blastogenesis. Am J Obstet Gynecol (1977) 129(1):14-20.
133. Cocchiara R, Lorico A, Cefalù E, Cittadini E, Geraci D. Modulation of lymphocyte response by hormones. Acta Eur Fertil (1983) 14(3):197-201.
134. Rolle L, Memarzadeh Tehran M, Morell-García A, Raeva Y, Schumacher A, Hartig R, et al. Cutting edge: IL-10-producing regulatory B cells in early human pregnancy. Am J Reprod Immunol (2013) 70(6):448-53. doi:10.1111/aji.12157
135. Hudic I, Fatušic Z. Progesterone - induced blocking factor (PIBF) and Th1/Th2 cytokine in women with threatened spontaneous abortion. J Perinat Med (2009) 37(4):338-42. doi:10.1515/JPM.2009.061
136. Ito A, Bebo BF, Matejuk A, Zamora A, Silverman M, Fyfe-Johnson A, et al. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol (2001) 167(1):542-52. doi:10.4049/jimmunol.167.1.542
137. McMurray RW, Ndebele K, Hardy KJ, Jenkins JK. 17-Beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine (2001) 14(6):324-33. doi:10.1006/cyto.2001.0900
138. Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol (2002) 168(3):1087-94. doi:10.4049/jimmunol.168.3.1087
139. Matalka KZ. The effect of estradiol, but not progesterone, on the production of cytokines in stimulated whole blood, is concentration-dependent. Neuro Endocrinol Lett (2003) 24(3-4):185-91.
140. Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG (2005) 112(8):1096-101. doi:10.1111/j.1471-0528.2005.00633.x
141. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav (2012) 62(3):263-71. doi:10.1016/j.yhbeh.2012.02.023
142. Pazos MA, Kraus TA, Muñoz-Fontela C, Moran TM, Deng JC. Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice. PLoS One (2012) 7(7):e40502. doi:10.1371/journal.pone.0040502
143. Hughes GC, Clark EA, Wong AH. The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses. J Leukoc Biol (2013) 93(3):369-75. doi:10.1189/jlb.1012491
144. Pantaleo M, Piccinno M, Roncetti M, Mutinati M, Rizzo A, Sciorsci R. Evaluation of serum concentrations of interleukin (IL)-4, IL-10, and IL-12 during pregnancy in bitches. Theriogenology (2013) 79(6):970-3. doi:10.1016/j.theriogenology.2013.01.017
145. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol (2009) 182(9):5488-94. doi:10.4049/jimmunol.0803177
146. Chen J-J, Lin DJ-Q, Liu MS-Y, Chien EJ. Non-genomic rapid responses via progesterone in human peripheral T cells are not indirectly mimicked by sphingosine 1-phosphate. Steroids (2013) 81:9-12. doi:10.1016/j.steroids.2013.11.011
147. Chien EJ, Chang C-P, Lee W-F, Su T-H, Wu C-H. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells. J Cell Biochem (2006) 99(1):292-304. doi:10.1002/jcb.20858
148. Hirano S, Furutama D, Hanafusa T. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells. Am J Physiol Regul Integr Comp Physiol (2007) 292(4):R1465-71. doi:10.1152/ajpregu.00778.2006
149. SundarRaj S, Mukhopadhyay D, Karande AA. Glycodelin A triggers mitochondrial stress and apoptosis in T cells by a mechanism distinct and independent of TCR signaling. Mol Immunol (2008) 45(8):2391-400. doi:10.1016/j.molimm.2007.11.004
150. Alok A, Karande AA. The role of glycodelin as an immune-modulating agent at the feto-maternal interface. J Reprod Immunol (2009) 83(1-2):124-7. doi:10.1016/j.jri.2009.06.261
151. Fraccaroli L, Grasso E, Zeitler E, Lombardi E, Gogorza S, Etchepareborda JJ, et al. Modulation of maternal LIF producers T cells by trophoblast and paternal antigens. Am J Reprod Immunol (2011) 65(2):133-45. doi:10.1111/j.1600-0897.2010.00890.x
152. Aisemberg J, Vercelli CA, Bariani MV, Billi SC, Wolfson ML, Franchi AM, et al. Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone. PLoS One (2013) 8(2):e56161. doi:10.1371/journal.pone.0056161
153. Shirshev SV. Molecular mechanisms of immunomodulating effect of chorionic gonadotropin on T- and B-lymphocytes of intact spleen. Biochemistry (Mosc) (1997) 62(5):514-22.
154. Khan NA, Khan A, Savelkoul HF, Benner R. Inhibition of diabetes in NOD mice by human pregnancy factor. Hum Immunol (2001) 62(12):1315-23. doi:10.1016/S0198-8859(01)00368-8
155. Khil L-Y, Jun H-S, Kwon H, Yoo JK, Kim S, Notkins AL, et al. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia (2007) 50(10):2147-55. doi:10.1007/s00125-007-0769-y
156. Dattwyler RJ, Tomasi TB. Inhibition of sensitization of T-cells by alpha-fetoprotein. Int J Cancer (1975) 16(6):942-5. doi:10.1002/ijc.2910160608
157. Peck AB, Murgita RA, Wigzell H. Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. III. Role of the MLC-stimulating cell population in alpha-fetoprotein-induced suppression of T cell-mediated cytotoxicity. J Immunol (1982) 128(3):1134-40.
158. Toder V, Blank M, Nebel L. Immunoregulatory mechanisms in pregnancy. 1. Evidence for the alpha-fetoprotein-induced generation of suppressor cells in vitro. Transplantation (1982) 33(1):41-4. doi:10.1097/00007890-198201000-00009
159. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod (2004) 10(5):347-53. doi:10.1093/molehr/gah044
160. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol (2005) 166(3):811-22. doi:10.1016/S0002-9440(10)62302-4
161. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod (2006) 12(5):301-8. doi:10.1093/molehr/gal032
162. Teles A, Schumacher A, Kühnle M-C, Linzke N, Thuere C, Reichardt P, et al. Control of uterine microenvironment by Foxp3+ cells facilitates embryo implantation. Front Immunol (2013) 4:158. doi:10.3389/fimmu.2013.00158
163. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol (2007) 178(4):2572-8. doi:10.4049/jimmunol.178.4.2572
164. Kallikourdis M, Betz AG. Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus? PLoS One (2007) 2(4):e382. doi:10.1371/journal.pone.0000382
165. Weinberg A, Enomoto L, Marcus R, Canniff J. Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation. J Reprod Immunol (2011) 89(1):70-7. doi:10.1016/j.jri.2010.11.009
166. Fuchs T, Hammarström L, Smith CI, Brundin J. In vitro induction of murine suppressor T-cells by human chorionic gonadotropin. Acta Obstet Gynecol Scand (1980) 59(4):355-9. doi:10.3109/00016348009154093
167. Fuchs T, Hammarström L, Smith CI, Brundin J. In vitro induction of human suppressor T cells by a chorionic gonadotropin preparation. J Reprod Immunol (1981) 3(2):75-84. doi:10.1016/0165-0378(81)90012-7
168. Fuchs T, Hammarström L, Smith CI, Brundin J. Sex-dependent induction of human suppressor T cells by chorionic gonadotropin. J Reprod Immunol (1982) 4(4):185-90. doi:10.1016/0165-0378(82)90025-0
169. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol (2004) 173(4):2227-30. doi:10.4049/jimmunol.173.4.2227
170. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology (2006) 118(1):58-65. doi:10.1111/j.1365-2567.2006.02339.x
171. Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol (2008) 214(2):456-64. doi:10.1002/jcp.21221
172. Mao G, Wang J, Kang Y, Tai P, Wen J, Zou Q, et al. Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice. Endocrinology (2010) 151(11):5477-88. doi:10.1210/en.2010-0426
173. Lin X-G, Zhou Q, Wang L, Gao Y, Zhang W-N, Luo Z-L, et al. Pregnancy estrogen drives the changes of T-lymphocyte subsets and cytokines and prolongs the survival of H-Y skin graft in murine model. Chin Med J (2010) 123(18):2593-9.
174. Valor L, Teijeiro R, Aristimuño C, Faure F, Alonso B, Andrés C, et al. Estradiol-dependent perforin expression by human regulatory T-cells. Eur J Clin Invest (2011) 41(4):357-64. doi:10.1111/j.1365-2362.2010.02414.x
175. Shirshev SV, Orlova EG, Zamorina SA, Nekrasova IV. Influence of reproductive hormones on the induction of CD4(+)CD25 (bright)Foxp (3+) regulatory T cells. Dokl Biol Sci (2011) 440:343-6. doi:10.1134/S0012496611050024
176. Xiong Y-H, Yuan Z, He L. Effects of estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood during pregnancy. Asian Pac J Trop Med (2013) 6(9):748-52. doi:10.1016/S1995-7645(13)60131-5
177. Thuere C, Zenclussen ML, Schumacher A, Langwisch S, Schulte-Wrede U, Teles A, et al. Kinetics of regulatory T cells during murine pregnancy. Am J Reprod Immunol (2007) 58(6):514-23. doi:10.1111/j.1600-0897.2007.00538.x
178. Zhao J-X, Zeng Y-Y, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol (2007) 75(2):71-81. doi:10.1016/j.jri.2007.06.052
179. Mjösberg J, Svensson J, Johansson E, Hellström L, Casas R, Jenmalm MC, et al. Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol. J Immunol (2009) 183(1):759-69. doi:10.4049/jimmunol.0803654
180. Mansour R, Tawab N, Kamal O, El-Faissal Y, Serour A, Aboulghar M, et al. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril (2011) 96(6):1370-4. doi:10.1016/j.fertnstert.2011.09.044
181. Chang X, Wu J. Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders. Gynecol Endocrinol (2013) 29(3):196-200. doi:10.3109/09513590.2012.736558
182. Davar R, Rahsepar M, Rahmani E. A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients. Arch Gynecol Obstet (2013) 287(1):149-53. doi:10.1007/s00404-012-2522-0
183. Lukassen HGM, Joosten I, van Cranenbroek B, van Lierop MJC, Bulten J, Braat DDM, et al. Hormonal stimulation for IVF treatment positively affects the CD56bright/CD56dim NK cell ratio of the endometrium during the window of implantation. Mol Hum Reprod (2004) 10(7):513-20. doi:10.1093/molehr/gah067
184. Zhou J, Wang Z, Zhao X, Wang J, Sun H, Hu Y. An increase of Treg cells in the peripheral blood is associated with a better in vitro fertilization treatment outcome. Am J Reprod Immunol (2012) 68(2):100-6. doi:10.1111/j.1600-0897.2012.01153.x